NASDAQ •
Healthcare •
Biotechnology •
Quote as of 08/14/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization307.42 mln
Float39.44 mln
Earnings Date11/10/2026
EPS
2.99
Solid
P / E
2.45
Deeply undervalued
Piotroski F-Score
6
/ 9
Solid
Beneish M-Score
26.77
Highly suspicious
1-Year Forecast
19.50
Transformational upside
Relative Strength
15
/ 100
Significantly lagging
Business Description
Agenus Inc. is a US-based biotechnology company focused on developing treatments that use the body's immune system to fight cancer and infectious diseases. Founded in 1994 and headquartered in Lexington, Massachusetts, the company has built a broad pipeline of experimental drugs, several of which are currently in clinical trials. Agenus works alongside major pharmaceutical partners including Bristol-Myers Squibb, Merck, Gilead Sciences, and Incyte Corporation to advance these treatments toward patients.
